Dr. Wysota is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1101 Chestnut St
Philadelphia, PA 19107Phone+1 215-955-8988
Education & Training
- Donald and Barbara Zucker School of Medicine at Hofstra/NorthwellClass of 2018
Certifications & Licensure
- PA State Medical License 2024 - 2026
- NY State Medical License 2021 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis.Nana Adjoa Ben-Crentsil, Wazim Mohammed Ismail, Maria E Balasis, Hannah Newman, Ariel Quintana
Cancer Discovery. 2024-12-02 - 8 citationsNovel Therapeutic Targets in Acute Myeloid Leukemia (AML).Michael Wysota, Marina Konopleva, Shane Mitchell
Current Oncology Reports. 2024-04-01 - 2 citationsInduction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma.Ana Acuna-Villaorduna, Viswanathan Shankar, Michael Wysota, Amanda Jirgal, Rafi Kabarriti
Cancer Control. 2022-10-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: